Halozyme Therapeutics (HALO) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference
HALOHalozyme(HALO)2022-01-13 04:56

Halozyme Confidential and Proprietary 40th Annual J.P. Morgan Healthcare Conference Dr. Helen Torley, President and CEO January 10, 2022 Halozyme Confidential and Proprietary 2 Forward-Looking Statements In addition to historical information, the statements set forth in this presentation include forward-looking statements including, without limitation, statements concerning the Company's expected future financial performance (including financial estimates for 2021 and outlook for 2022) and expectations for ...